| 24.60 Delayed Data As of 3:59pm ET |  -0.97 / -3.79%Today’s Change | 15.02 Today|||52-Week Range 29.44 | +25.90% Year-to-Date |
| Previous close | 25.57 |
| Today’s open | 25.47 |
| Day’s range | 24.23 - 25.47 |
| Volume | 2,073,723 |
| Average volume (3 months) | 1,824,717 |
| Market cap | $4.8B |
| Earnings growth (last year) | +82.28% |
| Earnings growth (this year) | -4.27% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | +14.33% |
| P/E ratio | 94.6 |
| Price/Sales | 2.69 |
| Price/Book | 4.14 |
| Today’s change | Today’s % change | |
|---|---|---|
| GRFSGrifols SA | -0.38 | -2.07% |
| TAROTaro Pharmaceutical ... | -7.27 | -7.13% |
| ALKSAlkermes Plc | -1.01 | -4.03% |
| UTHRUnited Therapeutics ... | -1.06 | -1.22% |
| Next reporting date | August 5, 2019 |
| EPS forecast (this quarter) | $0.40 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | -$74.2M |
| Net profit margin | -6.14% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Timothy P. Walbert |
Senior VP-Business Operations & Government Affairs Robert W. Metz |
Corporate headquarters Dublin, Dublin |
